# Kris Michelle

Kris Michelle writes and speaks about cannabis education, psychedelic policy, mental health, and community issues. Their posts connect public education and advocacy with practical concerns such as access to information, privacy, and stigma.

- Profile: https://b2binfluencer.marketing/creators/kris-michelle/
- LinkedIn: https://www.linkedin.com/in/kris-michelle-81ba1111
- LinkedIn followers: 7,054
- Topics: healthcare
- Based on 14 dated posts, latest 2026-09-05

## Summary

Kris Michelle is most useful for cannabis education and advocacy content tied to public access, stigma, privacy and community events.

- Best for: A Colorado cannabis education nonprofit or state-legal cannabis business education arm wanting stigma-reduction content and event promotion.
- Not for: Wellness technology selling at-home genetic tests for psychedelic or cannabis personalization and conversion-focused placements.
- Check first: Confirm recent post results, engagement, follower growth and audience survey data first.

### Takeaways

- Kris Michelle was one of four cannabis authors on a 2016 Rawlings Library panel.
- They argue libraries in a decriminalized state should carry and program cannabis material.
- A post quotes Infinite Healing's Shannon Tor saying clients are mostly aged 60 to 75.

## Main ideas

- **Drug policy should be argued as a public-health and criminal-justice problem**: Kris Michelle treats psychedelic medicalisation as inevitable and argues that the War on Drugs targets people who use drugs, not the drugs themselves. Drawing on survey and Bureau of Justice figures and one person's life story, the post ends by asking readers to petition for changes to the law rather than debate pharmacology.
- **Cannabis education belongs in libraries and other mainstream institutions**: As a participant in cannabis education, Kris Michelle argues that public libraries in decriminalised states have an obligation to stock and programme cannabis material. The case draws on librarianship's stated values: access to information, lifelong learning, democracy and intellectual freedom. The aim is to normalise cannabis education through credible civic settings, not promote it to existing enthusiasts.
- **Plant medicine is older than pharmacies and is reaching older Coloradans**: The post argues that herbalism, roots, tinctures and salves predate industrial drug manufacturing, and that Colorado now has a market where seniors use fungi and entheogenic substances for trauma and mental-health conditions. It attributes the medical claims to the practitioner, not to Kris Michelle—a distinction to preserve when reusing them.
- **Consumer wellness technology has to answer for how it handles personal data**: Kris Michelle examines the product's company structure, regulatory category and terms of service before stating a personal conclusion. The criticism targets data handling, not the substance; the post treats an uncomfortable psychedelic experience as an acceptable risk. This is the clearest counterweight to the legalisation-forward posts: it highlights the stakes when a psychedelics-adjacent business asks for something irreversible.
- **Sustained reading and attention are counterculture, and automation is eroding work**: Two posts argue that systems built around speed and efficiency are reshaping how people think and work. The first says reading trains empathy, memory, reasoning and focus, while constant scrolling works against those capacities. The second traces Labour Day and the eight-hour day through hybrid work and AI-driven efficiency, asking whether machines that need no health insurance or safety standards will replace human workers. Both criticise incentives rather than naming specific companies.
- **Mental health conversations should continue past awareness months, with concrete local action**: Kris Michelle marks the formal end of Men's Mental Health Month and argues that the conversation should continue, then points readers to a specific event with a venue, time and named contacts. The statistics make the case; the dinner is the call to action. The named contacts are foundation ambassadors, not clients or sponsors.

## Work to read

- [Cannabis education inside a public library](https://www.linkedin.com/posts/kris-michelle-81ba1111_books-library-neuroscience-activity-7444575066522259457-uRtk)
- [Herbalism, DMT and Colorado's older psychedelic clients](https://www.linkedin.com/posts/kris-michelle-81ba1111_colorado-shop-offers-dmt-microdosing-sessions-activity-7449540680135147520-diK4)
- [A conference report that becomes a drug-policy argument](https://www.linkedin.com/posts/kris-michelle-81ba1111_aspen-activity-7470320217064108032-v2vm)
- [A pointed critique of consumer DNA testing for psychedelics](https://www.linkedin.com/posts/kris-michelle-81ba1111_dna-psychedelics-datacollection-activity-7366515531757060096-CGkg)
- [Men's mental health, framed around a Denver dinner](https://www.linkedin.com/posts/kris-michelle-81ba1111_therealmentalhealthfoundation-hatsandchatstour-activity-7482648898046410752-LNWi)

## Brand relationships

- **EntheoDNA** (mention)
- **Infinite Healing** (mention)
- **THE REAL Mental Health Foundation** (mention)

## Partnerships

Kris Michelle's LinkedIn posts focus on advocacy and education around cannabis, psychedelics, mental health, and community events. They document no partnership format, sponsor policy, media kit, rate card, or inquiry process, and include no sponsored-content disclosures, mention of paid collaborations, or offer structure a brand could plan against. Commercial references are commentary on other organisations: a Colorado business selling plant-based preparations and DMT sessions, cited for its approach to traditional medicine, and a direct-to-consumer DNA testing kit pitched at psychedelic users, discussed critically for its privacy and regulatory risks. Neither reads as a promotional placement. For a cannabis education brand considering a content partnership, send a direct LinkedIn message with a scoped proposal covering topic, format, disclosure expectations, and budget; ask whether sponsored posts are accepted, what deliverables and timelines they offer, who handles commercial inquiries, and what documentation is available. Agree any partnership terms in writing before work starts.

## Alternatives

- Sky Bergman: Choose Sky Bergman when the priority is reaching and engaging older adults, not explaining cannabis. The two posts are written for that audience: they come from the Lives Well Lived: GENERATIONS project, make the case for sharing life across generations and end with a direct invitation to act, linking readers to a participation page. For an event or short series judged on attendance and conversation among readers over 60, Bergman already has that audience and an aging-affirming frame that keeps cannabis from reading as a youth or counterculture topic. The brand would supply the cannabis facts; Bergman would make the stigma-reduction argument that people of any age are allowed to be curious.
- Peter Hancock: Choose Peter Hancock only when the campaign runs through Colorado institutions rather than individual readers. The posts show Hancock chairing a Colorado workforce-development board, convening partners at named facilities, thanking hosts and partner organisations by name, and addressing an economic-development audience on talent pipelines and community collaboration. If the brand's route to non-users is an employer session, a library or civic board, or a Colorado partnership event where a stigma-reduction message can reach older professionals in a business setting, Hancock can assemble the room and speak to it credibly.
- Lavine Hemlani: Choose Lavine Hemlani only if the campaign shifts from consumer education to capital and industry. The posts explain UAE sovereign wealth, foreign-investment gaps and the country's coordinated push into biotech and drug discovery for an investor audience, using concrete figures, a numbered argument and a clear conclusion. If a client wants the plant-medicine or cannabis sector covered as a market-structure or investment story for funders or operators rather than first-time users, this register is the better fit, and the biotech-capital link to therapeutic development is genuine.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/